Ningbo MedicalSystem Valuation
| 300439 Stock | 11.43 0.05 0.44% |
At this time, the firm appears to be overvalued. Ningbo MedicalSystem secures a last-minute Real Value of USD9.32 per share. The latest price of the firm is USD11.43. Our model forecasts the value of Ningbo MedicalSystem from analyzing the firm fundamentals such as Current Valuation of 3.62 B, return on equity of 0.0933, and Profit Margin of 0.14 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.5258 | Enterprise Value 3.6 B | Enterprise Value Ebitda 12.28 | Price Sales 2.3708 | Trailing PE 17.3077 |
Overvalued
Today
Please note that Ningbo MedicalSystem's price fluctuation is somewhat reliable at this time. Calculation of the real value of Ningbo MedicalSystem is based on 3 months time horizon. Increasing Ningbo MedicalSystem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ningbo MedicalSystem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ningbo Stock. However, Ningbo MedicalSystem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.43 | Real 9.32 | Hype 11.49 | Naive 11.81 |
The real value of Ningbo Stock, also known as its intrinsic value, is the underlying worth of Ningbo MedicalSystem Company, which is reflected in its stock price. It is based on Ningbo MedicalSystem's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ningbo MedicalSystem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ningbo MedicalSystem Biotechnology helps investors to forecast how Ningbo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ningbo MedicalSystem more accurately as focusing exclusively on Ningbo MedicalSystem's fundamentals will not take into account other important factors: Ningbo MedicalSystem Cash |
|
Ningbo MedicalSystem Total Value Analysis
Ningbo MedicalSystem Biotechnology is presently forecasted to have takeover price of 3.62 B with market capitalization of 4.32 B, debt of 50.05 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ningbo MedicalSystem fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.62 B | 4.32 B | 50.05 M |
Ningbo MedicalSystem Investor Information
About 49.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.53. In the past many companies with similar price-to-book ratios have beat the market. Ningbo MedicalSystem last dividend was issued on the 7th of June 2024. The entity had 30:10 split on the 17th of September 2015. Based on the analysis of Ningbo MedicalSystem's profitability, liquidity, and operating efficiency, Ningbo MedicalSystem Biotechnology is performing exceptionally good at this time. It has a great odds to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 283.2 M | 253 M |
|
|
Ningbo MedicalSystem Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ningbo MedicalSystem has an asset utilization ratio of 54.05 percent. This suggests that the Company is making USD0.54 for each dollar of assets. An increasing asset utilization means that Ningbo MedicalSystem Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.Ningbo MedicalSystem Ownership Allocation
Ningbo MedicalSystem maintains a total of 383.95 Million outstanding shares. Ningbo MedicalSystem Biotechnology holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Ningbo MedicalSystem Profitability Analysis
The company reported the revenue of 1.89 B. Net Income was 256.55 M with profit before overhead, payroll, taxes, and interest of 949.62 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ningbo MedicalSystem's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ningbo MedicalSystem and how it compares across the competition.
About Ningbo MedicalSystem Valuation
The stock valuation mechanism determines Ningbo MedicalSystem's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ningbo MedicalSystem. We calculate exposure to Ningbo MedicalSystem's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ningbo MedicalSystem's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 841.2 M | 920.1 M |
Ningbo MedicalSystem Quarterly Retained Earnings |
|
Complementary Tools for Ningbo Stock analysis
When running Ningbo MedicalSystem's price analysis, check to measure Ningbo MedicalSystem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ningbo MedicalSystem is operating at the current time. Most of Ningbo MedicalSystem's value examination focuses on studying past and present price action to predict the probability of Ningbo MedicalSystem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ningbo MedicalSystem's price. Additionally, you may evaluate how the addition of Ningbo MedicalSystem to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |